<font color="red">Prevention_1</font> <font color="red">of_1</font> <font color="red">spinal_2</font> <font color="red">anesthesia_2</font> <font color="red">-_2</font> <font color="red">induced_2</font> <font color="red">hypotension_2</font> <font color="red">in_2</font> <font color="red">the_2</font> <font color="red">elderly_2</font> <font color="red">:_2</font> comparison between preanesthetic administration of crystalloids , colloids , and no prehydration . 
<br>
<br> The <font color="red">practice_1</font> <font color="red">of_1</font> <font color="red">routinely_2</font> <font color="red">prehydrating_2</font> <font color="red">patients_2</font> <font color="red">by_1</font> <font color="red">infusing_1</font> <font color="red">a_1</font> <font color="red">crystalloid_1</font> <font color="red">or_1</font> <font color="red">colloid_1</font> <font color="red">solution_1</font> <font color="red">(_1</font> <font color="red">up_1</font> <font color="red">to_1</font> <font color="red">1.0_1</font> <font color="red">L/70_1</font> <font color="red">kg_1</font> <font color="red">)_1</font> <font color="red">for_1</font> <font color="red">prevention_1</font> <font color="red">of_1</font> <font color="red">spinal_1</font> <font color="red">anesthesia_1</font> <font color="red">-_1</font> <font color="red">induced_1</font> <font color="red">hypotension_1</font> has been challenged recently , after several reports of failure to demonstrate its efficacy in young women . We compared the incidence and frequency of <font color="red">hypotension_1</font> <font color="red">and_1</font> <font color="red">vasopressor_1</font> <font color="red">therapy_1</font> <font color="red">after_1</font> <font color="red">spinal_1</font> <font color="red">anesthesia_1</font> <font color="red">and_1</font> <font color="red">no_1</font> <font color="red">prehydration_1</font> <font color="red">with_1</font> <font color="red">crystalloid_2</font> <font color="red">and_2</font> <font color="red">colloid_2</font> <font color="red">prehydration_2</font> <font color="red">in_2</font> <font color="red">elderly_4</font> <font color="red">patients_4</font> <font color="red">._4</font> <font color="red">Eighty_4</font> <font color="red">-_4</font> <font color="red">five_4</font> <font color="red">ASA_4</font> <font color="red">grade_4</font> <font color="red">I_4</font> <font color="red">or_4</font> <font color="red">II_4</font> <font color="red">patients_4</font> <font color="red">(_4</font> <font color="red">aged_4</font> <font color="red">60_4</font> <font color="red">-_4</font> <font color="red">89_4</font> <font color="red">yr_4</font> <font color="red">)_4</font> <font color="red">for_2</font> <font color="red">elective_2</font> <font color="red">total_2</font> <font color="red">hip_2</font> <font color="red">replacement_2</font> were randomized to receive 500 mL crystalloid solution ( Hartmanns , n = 29 ) , 500 mL colloid ( Haemaccel , n = 28 ) , or no prehydration ( n = 28 ) over 10 min prior to spinal anesthesia . Hypotension was defined as a 30% decrease from baseline systolic blood pressure ( BP ) or systolic < 90 mm Hg , and was treated with ephedrine 3-mg boluses . Although absolute systolic BP readings were significantly higher in the <font color="red">colloid_1</font> <font color="red">group_1</font> between 6 and 30 min ( P < 0.05 ) , the incidence of hypotension was not significantly different between the groups . The incidence of ephedrine use , incidence of nausea / vomiting , and median total dose of ephedrine were similar in all groups . We conclude that , <font color="red">in_1</font> <font color="red">elderly_3</font> <font color="red">patients_3</font> <font color="red">undergoing_2</font> <font color="red">elective_2</font> <font color="red">procedures_2</font> <font color="red">,_2</font> withholding prehydration is not associated with any greater degree of hypotension or need for vasopressor therapy compared with crystalloid or colloid prehydration .